Members of a working group appointed by House Speaker Nancy Pelosi, D-Calif., met Tuesday afternoon with U.S. Trade Representative Bob Lighthizer to discuss drug pricing provisions in the U.S.-Mexico-Canada Agreement (USMCA), Ways and Means Trade Chairman Earl Blumenauer, D-Ore., said. Blumenauer said Congress should be able to ratify USMCA by the end of the year.
While issues important to Democrats must be addressed, the lawmaker said he recognizes that Mexico’s newly elected president and the country will suffer if the U.S. takes too long to approve the agreement.
Meanwhile a group of Democratic lawmakers laid out their demands for supporting USMCA, including the reinstatement of Mandatory Country of Origin Labeling (COOL), something that few expect will happen.